Biotech Values

[DewDiligence]

Stephen Friend is leaving MRK after eight years. Dr. Friend
has been profiled in various posts on this board including
#msg-33080882, #msg-7088222, and #msg-11470542.

http://finance.yahoo.com/news/Dr-D-Gary-Gilliland-bw-14221889.html

Dr. Gilliland will replace Dr. Stephen H. Friend. Dr. Friend announced that he will be leaving the Company later this year to lead an effort to build open access integrative bionetworks, or complex databases, whereby scientific researchers around the world can collaborate on disease representations to advance collective scientific knowledge. The goal is to leverage collaboration to accelerate the elimination of human disease. Merck has been and will remain a key supporter of Dr. Friend on his ambitious and promising endeavor.